Three-dimensional quantitative structure-farnesyltransferase inhibition analysis for some diaminobenzophenones

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Drug Discovery

Background:

• Yeast farnesyltransferase (FT) is a validated target for antifungal drug development.
• Diaminobenzophenone derivatives have shown promise as FT inhibitors.
• Understanding structure-activity relationships is crucial for optimizing inhibitor design.

Purpose of the Study:

• To perform a 3D-QSAR investigation on a series of diaminobenzophenone yeast FT inhibitors.
• To identify key physicochemical properties governing the bioactivity of these inhibitors.
• To develop and validate predictive computational models for FT inhibition.

Main Methods:

• Utilized a dataset of 95 diaminobenzophenone yeast FT inhibitors.
• Employed 3D-Quantitative Structure-Activity Relationship (3D-QSAR) techniques, including Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA).
• Developed combined CoMFA/CoMSIA models incorporating steric, electrostatic, and hydrophobic fields.

Main Results:

• Steric, electrostatic, and hydrophobic properties were identified as critical determinants of yeast FT inhibitor bioactivity.
• A combined CoMFA/CoMSIA model demonstrated improved predictive power compared to a CoMFA-only model.
• Significant similarities were observed between 3D-QSAR field maps for yeast FT inhibition and previously reported antimalarial activities.

Conclusions:

• The study successfully elucidated the key structural and physicochemical drivers of bioactivity for diaminobenzophenone yeast FT inhibitors.
• Combined CoMFA/CoMSIA modeling offers enhanced predictive capabilities for designing novel FT inhibitors.
• The observed cross-activity correlations suggest potential for repurposing or developing dual-acting agents.